Monique Hinchcliff, MD, MS
Associate Professor of Medicine (Rheumatology, Allergy & Immunology); Director of Yale Scleroderma Program, Rheumatology, Allergy, & Immunology; Director of Clinical and Translational Research, Internal Medicine: Rheumatology; Associate Director, Internal Medicine: Rheumatology
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Dr. Monique Hinchcliff is Director of Clinical and Translational Research for Rheumatology, Allergy & Immunology at the Yale School of Medicine and the Director of the Yale Scleroderma Program. She received her medical degree from the Rosalind Franklin University Chicago Medical School and completed her medicine residency at Norwalk Hospital in Connecticut. She completed rheumatology fellowship training at Northwestern University Feinberg School of Medicine in Chicago, IL while earning a Master of Science degree in Clinical Investigation.
Her research program includes clinical, interventional and observational studies, with the goal of better understanding systemic sclerosis and identifying new and repurposed treatments for patients with systemic sclerosis. She has may active research collaborations both in the US and abroad. Clinically, Dr. Hinchcliff leads a team of multidisciplinary specialists with expertise in caring for patients with systemic sclerosis. She participates in ongoing clinical trials in order to give patients access to the latest treatments that may be beneficial.
Education & Training
- MSNorthwestern University (2010)
- MDRosalind Franklin University of Medicine and Science, The Chicago Medical School (2001)
- BABoston College, Music, Piano Performance (1995)
Activities
- The Scleroderma EsophagusCleveland, OH, United States 2023The Cleveland Clinic Rheumatology Research Conference.
- Molecular heterogeneity and personalized medicine in systemic sclerosis”.Hong Kong, Hong Kong 2023Rheumatologic Department of Seoul St. Mary's Hospital and the Catholic Rheumatism Research Center
- Hearts and Hands in SScNew York, NY, United States 2022New York University Rheumatology Grand Rounds
- A Patient-Directed Research Program in Systemic SclerosisLeeds, England, United Kingdom 2021Regional Rheumatology Rounds of Leeds Institute of Rheumatic and Musculoskeletal Medicine
- Beyond Skin in Systemic SclerosisSeattle, WA, United States 2021University of Washington, Department of Medicine, Section of Rheumatology Grand Rounds
- Five new treatments for patients with systemic sclerosisVirtual conference platform 2020Virtual Scleroderma World Congress
- Starting a Research Career in Translational Research”Atlanta, GA, United States 20192019 American College of Rheumatology Fellows in Training Educational Session.
- Biologic Classification of DiseaseAtlanta, GA, United States 20192019 American College of Rheumatology Biologic Classification of Disease Consensus Conference
- Starting a Career in Translational ResearchSan Diego, CA, United States 20172017 Fellows-In-Training Educational Session at the American College of Rheumatology Annual Scientific Meeting
- Translational Research in Systemic SclerosisNew Haven, CT, United States 2017Yale School of Medicine Rheumatology Grand Rounds
- The Scleroderma EsophagusNew York, NY, United States 2015New York University Langone Medical Center Division of Rheumatology Grand Rounds
- SclerodermaJackson County, MN, United States 2014Rheumatology Association 2014 Annual Meeting
- Gene Expression in SSc skin and esophagus provides insights into pathogenesisBirmingham, AL, United States 2013University of Alabama Birmingham Rheumatology Grand Rounds
- Autologous Stem Cell Transplant Outcomes in Systemic SclerosisMonteriggioni, Tuscany, Italy 2013Scleroderma World Congress Planning Meeting
- The utility of measuring gene expression in skin as a biomarker of systemic sclerosisSalt Lake City, UT, United States 2013University of Utah Rheumatology Grand Rounds
- Systemic Sclerosis: A Treatable Multi-System DiseaseChicago, IL, United States 2013Scleroderma Research Foundation Ninth Webinar.
- Novel High-throughput Biomarkers in SScSan Francisco, CA, United States 2013Scleroderma Research Foundation Annual Scientific Meeting
- Biomarker Studies.Stanford, CA, United States 2012“Gene Expression in Skin”: Biomarker Studies Rheumatology Grand Rounds speaker
- The utility of measuring gene expression in skin as a biomarker of systemic sclerosis.”Hanover, NH, United States 2012Geisel School of Medicine at Dartmouth Medical Center Rheumatology Interdisciplinary Research Rounds.
- Assessing gene expression before and after mycophenolate mofetil (Cellcept) treatment in skin biopsies from patients with scleroderma: the agony and the ecstasy of RNA microarray data analysis.Ann Arbor, MI, United States 2011University of Michigan First Tuesday Women's Health/BIRCWH/WRHR Interdisciplinary Research Career Development Series
- Fellows’ Subcommittee at the American College of Rheumatology Annual Scientific MeetingAtlanta, GA, United States 2010Navigating the American College of Rheumatology Annual Scientific Meeting
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| Top Doctor | Connecticut Magazine | 2022 |
| Top Doctor | Connecticut Magazine | 2021 |
| Top Doctor | Connecticut Magazine | 2020 |
| Scleroderma Center of Excellence | Scleroderma Foundation | 2019 |
| Excellence in Teaching Award | Northwestern University Feinberg School of Medicine Department of Medicine | 2018 |
| Excellence in Teaching Award | Northwestern University Feinberg School of Medicine Internal Medicine | 2017 |
| Excellence in Teaching Award | Northwestern University Feinberg School of Medicine Internal Medicine | 2016 |
| Excellence in Teaching Award | Northwestern University Feinberg School of Medicine Internal Medicine | 2015 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| AbbVie Fibrosis Group , AbbVie | Member | 2021 |
| Composite responder Index for Scleroderma Trials Assessing Limited scleroderma, CRISTAL Index | Member | 2021 - Present |
| Arthritis & Rheumatology | Editor | 2020 - 2023 |
| Department of Defense Systemic Sclerosis Stakeholders , Department of Defense Systemic Sclerosis | Virtual | 2020 |
| Pipeline and Early Clinical Development Boehringer Ingelheim , Boehringer Ingelheim Consultancy | Member | 2020 |
| 2019 Biologic Classification of Disease Consensus Conference , American College of Rheumatology | Atlanta, GA | 2019 |
| Rheumatology Advisory Board , AbbVie Global Commercial Development | Chicago, IL | 2018 |
| Physicians’ Education Resource , SSc-ILD; Optimizing the Diagnosis and Management | East Windsor, NJ | 2018 |
| Yale Pulmonary Hypertension Steering Committee | Member | 2018 - Present |
| Board of Medicine Directors , Scleroderma Foundation | Member | 2018 - Present |
| Bayer Healthcare Rheumatology Advisory Board, Bayer Healthcare | San Francisco, CA | 2015 |
| Arthritis Research and Therapy | Associate Editor | 2015 - Present |
| Journal of Scleroderma | Editorial Board Member | 2015 - Present |
| Evanston Northwestern Medical Education Committee | Representative | 2001 - 2002 |
Departments & Organizations
- Clinical and Translational Research Accelerator (CTRA)
- Hinchcliff Lab
- Human and Translational Immunology Program
- Internal Medicine
- Molecular Medicine, Pharmacology, and Physiology
- Program in Translational Biomedicine (PTB)
- Rheumatology
- Rheumatology, Allergy, & Immunology
- Scleroderma Program
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Medicine